Clinical Trial Update: Neoadjuvant ECS Versus ECF in Local Advanced Breast Cancer [Phase 4]

View source ↗

Summary

Phase 4 neoadjuvant trial comparing ECS versus ECF in locally advanced breast cancer; current status information is not provided.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• CISPLATIN (cisplatin)
• Epirubicin (epirubicin)

Snippet

Sponsor: Shandong University | Conditions: Breast Neoplasms, Neoadjuvant Therapy | Phase 4 | Status: UNKNOWN